NeuroSense Therapeutics (NRSNW) Q4 2024 Earnings

18DecConfirmed
Jun 21
Q2 2024
Q3 2024
Q4 2024
-0.35
-0.23
-0.12
0

Details

Expected EPS
-0.11
Actual EPS
-0.12
Surprise EPS
-0.01
Surprise Percent
+9.09%

Description

NeuroSense Therapeutics (NRSNW) has reported earnings of -0.12 per share for Q4 2024.

0 Comments

Share your thoughts